Bracco Imaging launches new subsidiary, Blue Earth Therapeutics, to advance development of next generation therapeutic radiopharmaceutical technology

Milan, Italy , 03/01/2022

As leaders in health care, we are strongly committed to the field of precision medicine. The creation of Blue Earth Therapeutics marks an exciting new direction for us in addressing unmet needs in patient health,” says Fulvio Renoldi Bracco.

Blue Earth Therapeutics is building a pipeline of precision targeted therapeutic radiopharmaceuticals, initially focused on prostate cancer, with plans to expand into additional disease areas in oncology.